Cytokinetics(CYTK) - 2023 Q4 - Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2023 Results Conference Call February 27, 2024 4:30 PM ET Company Participants Diane Weiser - SVP of Corporate Communication and IR Robert Blum - President and CEO Fady Malik - EVP of R&D Stuart Kupfer - SVP and Chief Medical Officer Andrew Callos - EVP and Chief Commercial Officer Robert Wong - VP and Chief Accounting Officer Conference Call Participants Mayank Mamtani - B. Riley Securities Carter Gould - Barclays Paul Choi - Goldman Sachs Adi Jayanthi - JP Morga ...